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j ourna l homepage: www.e lsev ie r .com/ locate /bbab ioEditorialIs mitochondrial free radical theory of aging getting old?Mitochondria are essential organelles found in every eukaryotic cell,
required to convert food into usable energy. Structures that may have
beenmitochondria were ﬁrst described by Jakob Henle in 1841 as gran-
ules in the sarcoplasm of striated muscle treated with acetic acid [1].
However, it was not until the oil immersion lens became available for
microscopes in 1870 and new tissue-staining techniques were devel-
oped by Richard Altmann, toward the end of the nineteenth century,
that these ﬁlaments that looked like strings of granules within nearly
all cells could be examined in more details [2]. Altmann proposed that
the granules, he called “bioblasts”, were basic living units within cells
that were responsible for metabolic processes [2]. Finally in 1898, Carl
Benda, published results using a different stain, crystal violet, to study
cells under the microscope. He investigated Altmann's bioblasts and
saw structures that sometimes looked like threads and at other times
resembled granules. He coined the term "mitochondrion" for them,
from the Greek words “mitos,” meaning “thread” and “chondros,”
meaning “granule,” with the plural being “mitochondria” [3]. In the
next few decades, many more scientists started working with the or-
ganelle, each of them discovering an important mitochondrial function
within the cell. Full discovery of mitochondria continued as the organ-
elle was harvested from the liver, giving scientists greater access to its
functions. Eugene Kennedy and Albert Lehninger showed how oxida-
tion occurs within mitochondria in 1950, and by 1978, Nobel Prize-
winner Peter D. Mitchell established his theory on chemiosmotics. He
described the diffusion of hydrogen ions across membranes, and its re-
lation to ATP during respiration in eukaryotic cells. This helped establish
the overall purpose of mitochondria, to work as the organelle that con-
verts the potential energy of food molecules into ATP.
Around the same time it became obvious that although mitochon-
dria arewonders of energy production, they also have another, less ben-
eﬁcial legacy in the cell [4]. This other property, the continuous
production of potentially harmful reactive oxygen species (ROS), has
become a central focus of aging research over the past sixty years after
Harman has proposed Mitochondrial Free Radical Theory of Aging
(MFRTA) [4]. Mitochondrial DNA damage is proposed to lead to the pro-
gressive accumulation of mutations during life, resulting in the synthe-
sis of dysfunctional mitochondrial energy system and therefore the
production of yet more ROS. An exponentially increasing rate of ROS
production is expected to lead eventually to catastrophic and irrevers-
ible damage to the cell itself. This may simply compromise the function
of specialized cell types, such as those dependent on mitochondrial en-
ergy for ion pumping at the cell surface, e.g. in kidney epithelium or in
neurons, or for providing the ATP required for such processes asmuscle
contraction or hormonal secretion [5]. In another scenario it can alter
the process of programmed cell death (apoptosis) in such way that
minor insults will lead to the progressive loss of specialized cells, andhttp://dx.doi.org/10.1016/j.bbabio.2015.08.004
0005-2728/© 2015 Elsevier B.V. All rights reserved.even of the stem cells that can replace them. Or it might actually raise
the apoptotic threshold, such that damaged cells are no longer removed,
but instead persist in a senescent state that destroys the physiological
integrity of the organism as a whole [5]. The evidence supporting
MFRTA have remained largely correlative, while the majority of experi-
mental data gathered over the last years havemainly disproved the cen-
tral role of ROS in aging. Despite this, the articles in this special issue
highlight how mitochondrial dysfunction retains a central position in
the aging theory.
The ﬁrst three reviews delvewith the topic ofmtDNAmutations and
aging, and discussmechanisms of origin and repair ofmtDNAmutations,
how they segregate in somatic tissues, and their phenotypic signiﬁcance
in aging tissues [6–8]. Overall, several studies have shifted the attention
from free radicals to replication errors as the main mechanism of origin
ofmtDNAmutations. ROS, on the other hand, have been rediscovered as
signalingmolecules playing a crucial role in several processes that affect
aging, such as cellular senescence [9] and stem cell homeostasis [10].
A wealth of evidence indicates a prominent role for mitochondrial
dysfunction in several common human diseases such as atherosclerosis,
osteoporosis, neurodegenerative, and cardiovascular diseases. Several
papers in this issue discuss in depth evidences, and controversies in
this ﬁeld [11–14]. The emerging picture is that mitochondrial dysfunc-
tion in human aging and aging-associated diseases are not limited to ac-
cumulation of mtDNA mutations, but extend to abnormalities in
mitochondria biogenesis, turnover, dynamics, and proteostasis. Is this
relevant at all to devise strategies to ﬁght aging and aging-associated
diseases? Notably, the beneﬁcial effect of dietary restriction on the
aging process is achieved in part through the attenuation of age-
related declines in mitochondrial function [15]. Moreover, a transcrip-
tional response activated by mitochondrial dysfunction, the mtUPR,
has been shown to have a beneﬁcial effect on life span [16].
Finally, this issue contains two original contributions to this exciting
ﬁeld. Lourenço et al. have studied themetabolome of worms deleted for
the prohibitin (PHB) complex to get an insight on the complex interplay
between this mitochondrial complex and longevity [17]. Maglioni et al.
have instead developed in Caenorhabditis elegans a high-content screen-
ing strategy to identify new potential pro-longevity interventions asso-
ciated with different degrees of respiratory dysfunction [18].
If the MFRTA is getting old, the ﬁeld of mitochondrial dysfunction
and aging is blooming, and is ﬁnally coming of age. This issue has tried
to recapitulate the main scientiﬁc achievements in recent years, to
give a glimpse of the relevance of this topic in many different areas,
and to stimulate challenging questions to be addressed in the future.
We would like to thank all the authors that have contributed, and the
reviewers that have helped in shaping this issue. Our gratitude also
goes tomembers of the editorial staff of the journal, in particular Tiffany
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